NewTradingView.com – Investing and Stock News
Investing and Stock News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Investing

Morgan Stanley just upgraded this large cap biotech stock

by September 9, 2022
written by September 9, 2022

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) is now back to near its year-to-date high but a Morgan Stanley analyst says the stock is not done pleasing its investors yet.

Regeneron stock has another 20% upside

On Friday, Matthew Harrison upgraded the biotech name to “overweight” and announced a price objective of $851 a share that translates to a 20% upside on its previous close. The analyst wrote:

Overall, we now see REGN as the preferred large cap growth name supported by a range of products delivering durable revenues and an advancing oncology pipeline with the potential to diversify the base business.

Interestingly, the bullish call arrives only days after insiders were reported to have sold $16 million worth of the Regeneron stock.

Last month, the Nasdaq-listed firm reported its financial results for the second quarter that topped Wall Street estimates.

What will drive future growth?

A day earlier, Regeneron Pharmaceuticals Inc said “Eylea” – its treatment for retinal diseases showed promising results in a trial when used in high dosage.

Harrison expects it will continue to grow share moving forward and also sees potential in “Dupixent” to be a catalyst for the stock as well. He added:

Investors underappreciated the impact of the recent co-stim data and we believe oncology can be a multi-billion-dollar franchise. We see novel assets like bio-specifics and costimulatory antibodies as the key to driving major upside.

Dupixent is the company’s monoclonal antibody for atopic dermatitis. That Tarrytown-headquartered company is currently trading at a forward price-to-earnings multiple of under 16.

The post Morgan Stanley just upgraded this large cap biotech stock appeared first on Invezz.

0 comment
0
FacebookTwitterPinterestEmail

previous post
Crypto relief: Bitcoin jumps 10% as it bounces from 10-month low
next post
Mark Mahaney wants you to be ‘long’ Spotify: find out why

You may also like

Disney Q1 earnings report: ‘this stock is unmatched...

February 9, 2023

Bank of America sees a 50% upside in...

February 8, 2023

Google stock loses 9.0% after it’s A.I event:...

February 8, 2023

Ex-Coinbase manager pleads guilty to insider trading charges

February 8, 2023

U.K. CMA issues provisional decision on Microsoft-Activision deal

February 8, 2023

Nasdaq 100 forecast – can index continue to...

February 8, 2023

Jim Cramer is bullish on Uber stock after...

February 8, 2023

Summary of Powell’s remarks and what it means...

February 8, 2023

Best undervalued Bill Ackman stocks for 2023

February 8, 2023

What’s happening to Chipotle stock in extended hours?

February 7, 2023
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Popular Posts

  • 1

    My Trigger to Enter $VAPR

  • 2

    Multi-Millionaire Trader Explains Why You Should Start Trading With A Small Account {VIDEO}

  • 3

    Scaling Up Tips From A 24-Year Old Millionaire Trader {VIDEO}

  • 4

    Pay Attention to These Stocks

  • 5

    New ‘Hunger Winter’ Looms as Europe Prepares to Shiver

Recent Posts

  • Disney Q1 earnings report: ‘this stock is unmatched anywhere else’

    February 9, 2023
  • Bank of America sees a 50% upside in this travel stock

    February 8, 2023
  • Google stock loses 9.0% after it’s A.I event: buy the dip?

    February 8, 2023
  • Ex-Coinbase manager pleads guilty to insider trading charges

    February 8, 2023
  • U.K. CMA issues provisional decision on Microsoft-Activision deal

    February 8, 2023

Categories

  • Economy (615)
  • Editor's Pick (235)
  • Investing (1,639)
  • Stock (9)
  • About Us
  • Email Whitelisting
  • Terms and Conditions
  • Privacy Policy
  • Contacts

Disclaimer: NewTradingView.com, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2023 NewTradingView.com All Rights Reserved.


Back To Top
NewTradingView.com – Investing and Stock News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick